# Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.

> **NCT03780894** · PHASE1,PHASE2 · COMPLETED · sponsor: **Banc de Sang i Teixits** · enrollment: 79 (actual)

## Conditions studied

- Polytrauma
- Traumatic Hemorrhage

## Interventions

- **DRUG:** Fibrinogen Concentrate (Human) 1 MG [RiaSTAP]
- **BIOLOGICAL:** Red blood cells concentrate
- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT03780894
- **Lead sponsor:** Banc de Sang i Teixits
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-21
- **Primary completion:** 2021-01-11
- **Final completion:** 2022-01-11
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03780894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03780894, "Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03780894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*